This 223-word story could have used 7 more, such as: “Observational studies can’t prove cause and effect.”
The Healthy Skeptic column does its usual fine job evaluating claims – this time about probiotic products.
On the eve of an FDA meeting about the Qnexa drug, this NPR blog post did a reasonable job capturing the tradeoffs and the review/approval dilemma for the FDA.
A muddy mix of test results, hints from unrelated research and shifting endpoints is likely to leave readers of this story confused about what evidence exists that a stop-smoking drug could help people who drink too much alcohol.
In one version of an online headline, WSJ.com trumpeted this as “The Diet That Saves The Brain.” That is simply unacceptable.
CNN avoided the easy Valentine’s Day tie-in for this heart story and gave readers a clear picture of both the study’s importance and its limitations. Better than WebMD’s effort.
A study this preliminary should have been handled with more caution, not heralded with “just in time for Valentine’s Day” hype. A CNN.com story was better.
Treatment for advanced ovarian tumors may lengthen survival, but questions still remain, despite the story’s emphasis on “promising” and “new hope.”
As with the HealthDay story on this research that we reviewed, readers of this story get a good dose of caveats and cautions along with the suggestions that electrical brain stimulation might someday “have implications” for treatment of Alzheimer’s disease.
The readers of this story and the other one we reviewed by Reuters are likely to understand that electrical brain stimulation could have some memory effects, but it’s a long way from becoming a treatment for Alzheimer’s disease.